Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Constrictive-effusive pericarditis as presenting feature of IgG4-related disease (IgG4-RD): a case report.

Created on 22 Jun 2026

Authors

Robert Fekete

Published in

Journal of medical case reports. Jun 21, 2026. Epub Jun 21, 2026.

Abstract

IgG4-Related Disease (IgG4-RD) is a fibroinflammatory disorder initially identified as autoimmune pancreatitis but subsequently shown in numerous other organs with common pathological hallmarks. Constrictive pericarditis is an unusual presentation of IgG4-RD.
This case report is about a 45-year-old previously healthy Slavic male patient with complicated course of IgG4-Related Disease (IgG4-RD) with pancreatic cyst, constrictive-effusive pericarditis potentially triggered by 3-month antecedent Coxsackie virus infection with hand foot and mouth syndrome, who had 495 cc pericardial fluid drained, bilateral pleural effusions with 1 L fluid drained from the right side. He was treated with methylprednisolone oral up to 48 mg daily. With each decrease in steroid dose (given maximum glucose on metabolic panel to 903) or holiday in steroid up to 6 weeks, he experienced worsening of positional and exertional shortness of breath. Final diagnosis and resolution of symptoms were obtained after pericardiectomy showing abundant fibrosis and plasma cells staining for IgG4. Remission was maintained on rituximab infusion.
This case highlights difficulty in diagnosing and treating IgG4-RD. His initial IgG4 serum level was normal to only mildly elevated. Definitive diagnosis was via tissue biopsy which required open heart surgery to access. Prior to the diagnosis, he was treated with methylprednisolone which led to severely elevated glucose levels. Oral steroids could not stop the progression of constrictive pericarditis. Pericardiectomy and subsequent treatment with rituximab led to continued remission.

PMID:
42324552
Bibliographic data and abstract were imported from PubMed on 22 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement